Back

Discontinuation of oral anticoagulation after successful atrial fibrillation treatment with radiofrequency and pulsed-field ablation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Workflows in atrial fibrillation ablation Oral Anticoagulation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Paolo China

Hospital dell'Angelo, Mestre-Venice (Italy)

6 More presentations in this session

Presentation thumbnail
Feasibility and safety of pulsed-field ablation in atrial fibrillation patients with septal occluder devices: a multicenter case series
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Strategy-specific effects of low-voltage area-targeted ablation added to pulmonary vein isolation: a meta-analysis of randomized controlled trials
Doctor A. Sunaga (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Retrospective evaluation of the prostyle vascular closure device in patients undergoing atrial fibrillation ablation: effects on hemostasis and hospital stay.
Miss I. Bax (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Real-world comparison of spherical pulsed field and point-by-point radiofrequency ablation for pulmonary vein isolation: insights from the best ablate registry
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Bilateral left lateral ridge ablation in patients with paroxysmal atrial fibrillation: study rationale and preliminary results
Doctor D. Ciliberti (Casamassima, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Workflows in atrial fibrillation ablation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Can we stop anticoagulation following 'successful' atrial fibrillation ablation?
thumbnail
Congress Session
HOT LINE 8
thumbnail
Congress Session
Late-Breaking Science: paroxysmal atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources